SCHEMBL21442286

SCHEMBL21442286

CC(N)(C[C@H](O)C(F)(F)F)c1nc(Br)ccc1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15991423 1.00 — —
SCHEMBL15990919 1.00 — —
SCHEMBL18707692 0.89 CYP1A2 (0.31) —
SCHEMBL16166091 0.85 — —
SCHEMBL16166138 0.84 GAA (0.33) —
SCHEMBL15991076 0.82 — —
SCHEMBL15990990 0.82 — —
SCHEMBL20606729 0.76 — —
SCHEMBL20606727 0.76 — —
SCHEMBL20606730 0.76 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2961749-B1 PERFLUORINATED 5,6-DIHYDRO-4H-1,3-OXAZIN-2-AMINE COMPOUNDS AS BETA-SECRETASE INHIBITORS AND METHODS OF USE AMGEN INC (US) 2019-10-09 — — EP disclosed
Send feedback